Supplementary Figure – PD-L1 expression and overall survival in Asian and western patients with gastric cancer
figureposted on 2022-05-26, 08:54 authored by Figshare Future Science GroupFigshare Future Science Group, Sun Young Rha, Geoffrey Y Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly A Fein, Laura H Tang, Wei Zhou, Senaka A Peter, Ting Wu, David P Kelsen, Jaffer A Ajani
Supplementary Figure S1. Histogram of PD-L1 expression based on CPS in the overall cohort (N = 574). CPS, combined positive score; PD-L1, programmed death ligand 1.
Supplementary Figure S2. OS by PD-L1 expression in (A) South Korean patients by disease stage and (B) US patients by disease stage. OS, overall survival; PD-L1, programmed death ligand 1.
Supplementary Figure S3. OS by PD-L1 expression using a CPS cutoff of 10 for (A) all patients (n = 574), (B) stage I-III patients (n = 290) and stage IV patients (n = 277). CPS, combined positive score; PD-L1, programmed death ligand 1.
Supplementary Figure S4. GEP score for all patients and by (A) stage and (B) tissue type. GEP, gene expression profile.